Gauzy’s (NASDAQ:GAUZ – Get Free Report) lock-up period is set to expire on Tuesday, December 3rd. Gauzy had issued 4,411,765 shares in its initial public offering on June 6th. The total size of the offering was $75,000,005 based on an initial share price of $17.00. After the end of Gauzy’s lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted.
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on GAUZ. Barclays cut their price target on Gauzy from $24.00 to $15.00 and set an “overweight” rating on the stock in a report on Wednesday, November 13th. TD Cowen cut their target price on Gauzy from $24.00 to $18.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Finally, B. Riley cut their target price on Gauzy from $15.50 to $14.00 and set a “buy” rating on the stock in a research note on Wednesday, November 13th.
Check Out Our Latest Research Report on GAUZ
Gauzy Trading Down 1.5 %
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the business. Ibex Investors LLC acquired a new position in shares of Gauzy during the second quarter valued at $40,030,000. Driehaus Capital Management LLC bought a new position in Gauzy in the 2nd quarter valued at about $4,289,000. Millennium Management LLC bought a new position in Gauzy in the 2nd quarter valued at about $2,824,000. Ghisallo Capital Management LLC acquired a new position in Gauzy during the 2nd quarter valued at about $1,491,000. Finally, Empyrean Capital Partners LP acquired a new position in Gauzy during the 2nd quarter valued at about $1,202,000.
About Gauzy
Gauzy Ltd. is a fully-integrated light and vision control company which focused on the research, development, manufacturing and marketing of vision and light control technologies. It operates principally in Germany, France, the United States, Canada, China, Singapore and Dubai. Gauzy Ltd. is headquartered in Tel Aviv, Israel.
Featured Stories
- Five stocks we like better than Gauzy
- What is a Dividend King?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- 3 Warren Buffett Stocks to Buy Now
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Invest in Biotech Stocks
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Gauzy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gauzy and related companies with MarketBeat.com's FREE daily email newsletter.